This section will contain updates from the pain industry.

Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics

Eli Lilly and Company announced a license agreement to acquire the exclusive worldwide rights for CNTX-0290 from Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain. CNTX-0290, is a novel, small molecule somatostatin receptor type 4 (SSTR4) agonist that is currently being studied in Phase 1 clinical testing as a potential non-opioid treatment for chronic pain conditions. 

Continue reading
Topics:

FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device

Theranica, a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that the U.S. Food and Drug Administration (FDA) granted a De Novo request for its smartphone-controlled electroceutical, Nerivio Migra®, utilizing Remote Electrical Neuromodulation for the acute treatment of migraine. 

Continue reading

Kailo Labs Launches the World’s First Nanotech Bio-Antenna for Pain Relief

Kailo Labs, an Utah-based nanotech startup, has launched the world's first nanotechnology-based bio-antenna for easy pain relief.  Full story.  
Topics:

Prospective Data Demonstrates Effective Pain Relief and Improved Function Using Medtronic's Evolve(SM) Workflow with Spinal Cord Stimulation

Medtronic today announced primary endpoint (3-month) results of the Vectors Post Market Clinical Study that demonstrated effective pain relief and improved function in patients with chronic intractable back and leg pain treated with spinal cord stimulation (SCS) utilizing the EvolveSM workflow

Continue reading
Topics:
SCS

Join AAPM in Thanking the Following Companies for their Support

The AAPM Corporate Relations Council (CRC) is a distinguished community of healthcare professionals with a sustained interest in pain disorders and pain management. Thanks to these companies for supporting the Academy's goals and mission.

Continue reading

Aegis Science Corporation Presents Corporate Showcase at AAPM35

View the 30-minute webinar : Are drug interactions harming your patients? Enhance DDI identification and patient care with Interact Rx™ Presented by Josh Schrecker, Pharm.D., Clinical Scientist, Healthcare Services, Aegi...
Continue reading
Topics:
DDI

Medtronic Announces FDA Clearance and U.S. Launch of the Accurian Radio Frequency System for Nerve Tissue Ablation

​ Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio frequency (RF) ablation of nerve tissues. RF ablatio...
Continue reading

KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of APADAZ®

 KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today that the U.S. Food and Drug Administration (FDA) has approved a Sup...
Continue reading

AAPMF Pain Medicine Education Program for Daiichi Sankyo Reps

The AAPM Foundation has launched a pain medicine education program (PMEP) specifically designed for 300 Daiichi Sankyo sales representatives. The course aims to further representatives' knowledge, confidence, and credibi...
Continue reading